Expected difference in formulations [Power / Sample Size]

posted by Ahmed meeran – 2006-11-01 13:37 (6750 d 12:46 ago) – Posting: # 351
Views: 12,014

Dear Dr. Helmut,

Even if we account for CV as you have discussed, How could we account for the difference in the formulation for test and reference to calculate the sample size.

n > [t(alpha, 2n-2) + t(beta, 2n-2)]2 [CV/(20-eta)]2,
where eta = 100 x theta/µR = 100 x (µT - µR)/ µR

EQN is referred from ANVISA.

With regards,

D.Ahmed

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
26 visitors (0 registered, 26 guests [including 6 identified bots]).
Forum time: 03:23 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5